Early Access

Back to REGN

REGENERON PHARMACEUTICALS, INC. Total Assets 2009-2025 | REGN

Beta

What is total assets?

Total assets can be defined as the sum of all current and non-current resources owned by a company that have economic value.

What is REGENERON PHARMACEUTICALS, INC.'s current total assets?

REGENERON PHARMACEUTICALS, INC. (REGN) annual total assets for 2025 was $40.56B, a 7.41% increase from 2024. REGENERON PHARMACEUTICALS, INC. total assets for the quarter ending December 31, 2025 was $40.56B.

What was REGENERON PHARMACEUTICALS, INC.'s total assets in 2024?

REGENERON PHARMACEUTICALS, INC. annual total assets for 2024 was $37.76B, a 14.15% increase from 2023.

What was REGENERON PHARMACEUTICALS, INC.'s total assets in 2023?

REGENERON PHARMACEUTICALS, INC. annual total assets for 2023 was $33.08B, a 13.23% increase from 2022.

What is REGENERON PHARMACEUTICALS, INC.'s 5-year total assets CAGR?

REGENERON PHARMACEUTICALS, INC. total assets grew at a compound annual growth rate (CAGR) of 18.77% from FY2020 to FY2025, going from $17.16B to $40.56B over 5 years.

Total Assets History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+18.8%
FY2020
$17.16B
FY2025
$40.56B
0910111213141516171819202122232425
5 years selected
Total Assets History
PeriodValueChangeSource
FY2025$40.56B+7.4%10-K
FY2024$37.76B+14.1%10-K
FY2023$33.08B+13.2%10-K
FY2022$29.21B+14.9%10-K
FY2021$25.43B+48.2%10-K
FY2020$17.16B+15.9%10-K
FY2019$14.81B+26.2%10-K
FY2018$11.73B+33.9%10-K
FY2017$8.76B+25.7%10-K
FY2016$6.97B+24.3%10-K
FY2015$5.61B+46.2%10-K
FY2014$3.84B+30.0%10-K
FY2013$2.95B+41.8%10-K
FY2012$2.08B+57.2%10-K
FY2011$1.32B+21.5%10-K
FY2010$1.09B+47.0%10-K
FY2009$741.2M-10-K
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →